Abstract
Despite being a common condition in pregnancy, and despite propylthiouracil (PTU) being perceived as safer than methimazole, there are virtually no epidemiological controlled studies on malformation rate an neurobehavioral outcomes with the former. This knowledge gap must be filled to ensure fetal safety.
Original language | English |
---|---|
Pages (from-to) | 12-13 |
Number of pages | 2 |
Journal | Therapeutic Drug Monitoring |
Volume | 28 |
Issue number | 1 |
DOIs | |
State | Published - Feb 2006 |
Externally published | Yes |
Keywords
- Antithyroid
- Malformations
- Pregnancy
- Therapeutic drug monitoring
- Thyrotoxicosis